Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial by Bruix, Jordi, Dr, Qin, Shukui, Prof, Merle, Philippe, Prof, Granito, Alessandro, MD, Huang, Yi-Hsiang, Prof, Bodoky, György, MD, Pracht, Marc, MD, Yokosuka, Osamu, Prof, Rosmorduc, Olivier, Prof, Breder, Valeriy, MD, Gerolami, René, Prof, Masi, Gianluca, MD, Ross, Paul J, FRCP, Song, Tianqiang, PhD, Bronowicki, Jean-Pierre, Prof, Ollivier-Hourmand, Isabelle, MD, Kudo, Masatoshi, Prof, Cheng, Ann-Lii, Prof, Llovet, Josep M, Prof, Finn, Richard S, MD, LeBerre, Marie-Aude, MSc, Baumhauer, Annette, MD, Meinhardt, Gerold, MD, Han, Guohong, Prof

Get full text

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study by Faivre, Sandrine, Prof, Raymond, Eric, Prof, Boucher, Eveline, MD, Douillard, Jean, Prof, Lim, Ho Y, MD, Kim, Jun S, MD, Zappa, Magaly, MD, Lanzalone, Silvana, MSc, Lin, Xun, PhD, DePrimo, Samuel, PhD, Harmon, Charles, PhD, Ruiz-Garcia, Ana, PhD, Lechuga, Maria J, MD, Cheng, Ann Lii, Prof

Get full text

Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012 by Ku, Geoffrey, MD, Tan, Iain BeeHuat, MBBS, Yau, Thomas, MBBS, Boku, Narikazu, MD, Laohavinij, Sudsawat, MD, Cheng, Ann-Lii, Prof, Kang, Yoon-Koo, Prof, de Lima Lopes, Gilberto, Dr

Get full text